Literature DB >> 29633720

Use of active personal dosimeters in hospitals: EURADOS survey.

Olivera Ciraj-Bjelac1, Eleftheria Carinou, Filip Vanhavere.   

Abstract

Considering that occupational exposure in medicine is a matter of growing concern, active personal dosimeters (APDs) are also increasingly being used in different fields of application of ionising radiation in medicine. An extensive survey to collect relevant information regarding the use of APDs in medical imaging applications of ionising radiation was organised by the EURADOS (European Radiation Dosimetry Group) Working Group 12. The objective was to collect data about the use of APDs and to identify the basic problems in the use of APDs in hospitals. APDs are most frequently used in interventional radiology and cardiology departments (54%), in nuclear medicine (29%), and in radiotherapy (12%). Most types of APDs use silicon diodes as the detector; however, in many cases their calibration is not given proper attention, as radiation beam qualities in which they are calibrated differ significantly from those in which they are actually used. The survey revealed problems related to the use of APDs, including their reliability in pulsed x-ray fields that are widely used in hospitals. Guidance from regulatory authorities and professional organisations on the testing and calibration of APDs used in hospital would likely improve the situation.

Entities:  

Mesh:

Year:  2018        PMID: 29633720     DOI: 10.1088/1361-6498/aabce1

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  2 in total

1.  High filtration in interventional practices reduces patient radiation doses but not always scatter radiation doses.

Authors:  Roberto M Sanchez; Eliseo Vano; Pablo Salinas; Nieves Gonzalo; Javier Escaned; Jose M Fernández
Journal:  Br J Radiol       Date:  2020-11-24       Impact factor: 3.039

2.  Characterisation and mapping of scattered radiation fields in interventional radiology theatres.

Authors:  M Nowak; P Carbonez; M Krauss; F R Verdun; J Damet
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.